| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Research Articles
Scientists found that CCK and its variants work independently of the levels of insulin in the bloodstream. But interestingly, only a few days of high fat intake create a resistance to CCK that is similar to insulin resistance.
Canadian scientists have reported that a hormone found in the gut has the power to lower glucose production by signaling the brain and liver to do so. When the researchers activated its receptors in lab rats, they found that the hormone, called cholecystokinin (CCK) peptide, rapidly lowered the animals' blood glucose levels.
However, they also found a drawback: CCK's power is blunted when there are high levels of fat in the bloodstream. In rodents that were fed a high-fat diet for three days, the hormone failed to have any effect on glucose levels.
CCK lowers glucose production by binding the receptors of nerves in the small intestine and making them send a signal to the brain to stop production. The brain, in turn, sends the command to the liver.
The scientists found that CCK and its variants work independently of the levels of insulin in the bloodstream. But the fly in the ointment is the introduction of fat into the diet. Only a few days of high fat intake create a resistance to CCK that is similar to insulin resistance.
If the researchers can duplicate CCK's effects in humans, the next goal will be to find a way to get the hormone to work despite high bloodstream fat levels. If so, it could become the basis of a more benign therapy that works by lowering glucose production, but not by addressing the liver directly.
The Canadians published their findings in the August 2009 issue of Cell Metabolism in an article called, "Intestinal Cholecystokinin Controls Glucose Production Through a Neuronal Network."
Categories: Blood Sugar, Community, Health, Health Care, Pre-Diabetes, Research
0 comments -
Aug 27, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.